Breath analysis for in vivo detection of pathogens related to ventilator-associated pneumonia in intensive care patients: A prospective pilot study

Journal of Breath Research

Volumn 9, Issue 1, 2015, Pages

  Filipiak, Wojciech ^a,b   Beer, Ronny ^b   Sponring, Andreas ^a,b   Filipiak, Anna ^a,b   Ager, Clemens ^a,b   Schiefecker, Alois ^b   Lanthaler, Simon ^a   Helbok, Raimund ^b   Nagl, Markus ^b   Troppmair, Jakob ^b   Amann, Anton ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

adsorptive sample preconcentration; bacteria derived metabolites; breath analysis; breath markers; gas chromatography mass spectrometry (GC MS); mechanically ventilated (MV) patients; ventilator associated pneumonia (VAP); volatile organic compounds (VOCs)

Indexed keywords

1,3 BUTADIENE; 2,3 BUTANEDIONE; ACETALDEHYDE; ACETIC ACID; ACETIC ACID ETHYL ESTER; ACETOIN; ACETONITRILE; ALCOHOL; BENZALDEHYDE; BUTANE; BUTANOL; BUTYRALDEHYDE; DIMETHYL DISULFIDE; DIMETHYL SULFIDE; HEXANAL; HYDROCARBON; ISOBUTANOL; ISOBUTYLENE; ISOBUTYRALDEHYDE; ISOPENTYL ACETATE; ISOPENTYL ALCOHOL; ISOVALERALDEHYDE; ISOVALERIC ACID; METHACRYLIC ACID METHYL ESTER; METHANETHIOL; METHANOL; PROPANE; PROPANOL; PROPIONALDEHYDE; PYRROLE; VOLATILE ORGANIC COMPOUND;

ACHROMOBACTER; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL LOAD; BACTERIUM CULTURE; BACTERIUM ISOLATION; BREATH ANALYSIS; BURKHOLDERIA MULTIVORANS; CANDIDA ALBICANS; CANDIDIASIS; CAPNOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; HEMOLYTIC STREPTOCOCCUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTENSIVE CARE; INTENSIVE CARE UNIT; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MASS FRAGMENTOGRAPHY; MICROORGANISM DETECTION; MIDDLE AGED; NONHUMAN; PATIENT CARE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; TIDAL VOLUME; VENTILATOR ASSOCIATED PNEUMONIA; VERY ELDERLY; ADOLESCENT; EARLY DIAGNOSIS; ESCHERICHIA COLI INFECTIONS; FEASIBILITY STUDY; FEMALE; MALE; MICROBIOLOGY; PNEUMONIA, VENTILATOR-ASSOCIATED; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BREATH TESTS; CANDIDIASIS; EARLY DIAGNOSIS; ESCHERICHIA COLI INFECTIONS; FEASIBILITY STUDIES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PILOT PROJECTS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 84922365030     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/9/1/016004     Document Type: Article

References (81)

1. Wunderink R G, Woldenberg L S, Zeiss J, Day C M, Ciemins J and Lacher D A 1992 The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia Chest 101 458-63
2. Morrow L E and Kollef M H 2010 Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation Crit. Care Med. 38 S352-62
3. Rea-Neto A et al 2008 Diagnosis of ventilator-associated pneumonia: a systematic review of the literature Crit. Care 12 R56
4. Vincent J L, de Souza Barros D and Cianferoni S 2010 Diagnosis, management and prevention of ventilator-associated pneumonia: an update Drugs 70 1927-44
5. Klompas M 2009 The paradox of ventilator-associated pneumonia prevention measures Crit. Care 13 315
6. Beyersmann J et al 2006 Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection Infect. Control Hosp. Epidemiol. 27 493-9
7. Tejerina E et al 2010 Accuracy of clinical definitions of ventilator-associated pneumonia: comparison with autopsy findings J. Crit. Care 25 62-8
8. Torres A, Fabregas N, Ewig S, de la Bellacasa J P, Bauer T T and Ramirez J 2000 Sampling methods for ventilator-associated pneumonia: validation using different histologic and microbiological references Crit. Care Med. 28 2799-804
9. Tejada Artigas A et al 2001 Risk factors for nosocomial pneumonia in critically ill trauma patients Crit. Care Med. 29 304-9
10. Fagon J Y et al 2000 Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia a randomized trial Ann. Intern. Med. 132 621-30
11. Rello J, Gallego M, Mariscal D, Sonora R and Valles J 1997 The value of routine microbial investigation in ventilator-associated pneumonia Am. J. Respir. Crit. Care Med. 156 196-200
12. Leroy O, Meybeck A, d'Escrivan T, Devos P, Kipnis E and Georges H 2003 Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia Intensive Care Med. 29 2170-3
13. Dupont H, Mentec H, Sollet J P and Bleichner G 2001 Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia Intensive Care Med. 27 355-62
14. Leone M et al 2007 Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse Crit. Care Med. 35 379-85
15. Kollef M H 2012 Prevention of ventilator-associated pneumonia or ventilator-associated complications: a worthy, yet challenging, goal Crit. Care Med. 40 271-7
16. Chastre J 2008 Evolving problems with resistant pathogens Clin. Microbiol. Infect. 14 3-14
17. Kollef M H 2000 Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients Clin. Infect. Dis. 31 S131-8 (Suppl 4)
18. Luna C M et al 2003 Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome Crit. Care Med. 31 676-82
19. Deurenberg R H, Vink C, Kalenic S, Friedrich A W, Bruggeman C A and Stobberingh E E 2007 The molecular evolution of methicillin-resistant S.aureus Clin. Microbiol. Infect. 13 222-35
20. Fridkin S K et al 2003 Epidemiological and microbiological characterization of infections caused by S. Aureus with reduced susceptibility to vancomycin United States, 1997-2001 Clin. Infect. Dis. 36 429-39
21. Weigel L M et al 2007 High-level vancomycin-resistant S. Aureus isolates associated with a polymicrobial biofilm Antimicrob. Agents Chemother 51 231-8
22. Trouillet J L, Vuagnat A, Combes A, Kassis N, Chastre J and Gibert C 2002 Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms Clin. Infect. Dis. 34 1047-54
23. Neuhauser M M, Weinstein R A, Rydman R, Danziger L H, Karam G and Quinn J P 2003 Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use JAMA: J. Am. Med. Assoc. 289 885-8
24. Macht M, Robinson J C and Graham B B 2013 Updated approach for the assessment of ventilator-associated pneumonia Crit. Care Med. 41 2641-2
25. Erhart S et al 2009 3-Heptanone as a potential new marker for valproic acid therapy J. Breath Res. 3 016004
26. Liao C C et al 2002 The 13C-urea breath test to detect Helicobacter pylori infection: a validated simple methodology with 50 mg 13C-urea Aliment. Pharmacol. Ther. 16 787-92
27. Hakim M et al 2012 Volatile organic compounds of lung cancer and possible biochemical pathways Chem. Rev. 112 5949-66
28. Schubert J K, Muller W P, Benzing A and Geiger K 1998 Application of a new method for analysis of exhaled gas in critically ill patients Intensive Care Med. 24 415-21
29. Refat M, Moore T J, Kazui M, Risby T H, Perman J A and Schwarz K B 1991 Utility of breath ethane as a noninvasive biomarker of vitamin E status in children Pediatr. Res. 30 396-403
30. Artlich A, Jonsson B, Bhiladvala M, Lonnqvist P A and Gustafsson L E 2001 Single breath analysis of endogenous nitric oxide in the newborn Biol. Neonate 79 21-6
31. Filipiak W et al 2012 Molecular analysis of volatile metabolites released specifically by S.aureus and Pseudomonas aeruginosa BMC Microbiol. 12 113
32. Filipiak W et al 2012 Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS Microbiology 158 3044-53 (Pt 12)
33. Filipiak W S A, Filipiak A, Baur M, Ager C, Wiesenhofer H, Margesin R, Nagl M, Troppmair J and Amann A 2013 Volatile organic compounds (VOCs) released by pathogenic microorganisms in vitro: potential breath biomarkers for early-stage diagnosis of disease Volatile Biomarkers: Non-Invasive Diagnosis in Physiology and Medicine 1st edn ed A S Amann (India: Elsevier) pp 475-24
34. Filipiak W et al 2010 TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro Cancer Epidemiol. Biomark. Prev. 19 182-95
35. Filipiak W et al 2008 Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro Cancer Cell Int. 8 17
36. Sponring A et al 2010 Analysis of volatile organic compounds (VOCs) in the headspace of NCIH1666 lung cancer cells in vitro Cancer Biomark. 7 1-9
37. Sponring A et al 2009 Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro Anticancer Res. 29 419-26
38. Adair C G et al 1999 Implications of endotracheal tube biofilm for ventilator-associated pneumonia Intensive Care Med. 25 1072-6
39. Roux D et al 2009 C. Albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat Crit. Care Med. 37 1062-7
40. Venkatesh M P, Pham D, Fein M, Kong L and Weisman L E 2007 Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and C. Albicans: fluconazole prophylaxis enhances survival and growth Antimicrob. Agents Chemother. 51 1240-5
41. Carlson E 1983 Effect of strain of S. Aureus on synergism with C. Albicans resulting in mouse mortality and morbidity Infect. Immun. 42 285-92
42. Eggimann P, Garbino J and Pittet D 2003 Epidemiology of Candida species infections in critically ill non-immunosuppressed patients Lancet Infect. Dis. 3 685-702
43. Azoulay E et al 2004 Practices in non-neutropenic ICU patients with Candida-positive airway specimens Intensive Care Med. 30 1384-9
44. Beer R, Pfausler B and Schmutzhard E 2010 Infectious intracranial complications in the neuro-ICU patient population Curr. Opin. Crit. Care 16 117-22
45. Broessner G et al 2007 Survival and long-term functional outcome in 1,155 consecutive neurocritical care patients Crit. Care Med. 35 2025-30
46. Helbok R et al 2012 Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients Crit. Care. 16 R226
47. Klompas M et al 2012 Rapid and reproducible surveillance for ventilator-associated pneumonia Clin. Infect. Dis. 54 370-7
48. Filipiak W, Filipiak A, Ager C, Wiesenhofer H and Amann A 2012 Optimization of sampling parameters for collection and preconcentration of alveolar air by needle traps J. Breath Res. 6 027107
49. Filipiak W et al 2012 Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants J. Breath Res. 6 036008
50. Davies S, Spanel P and Smith D 1997 Quantitative analysis of ammonia on the breath of patients in end-stage renal failure Kidney Int. 52 223-8
51. Perri F, Marras R M, Ricciardi R, Quitadamo M and Andriulli A 2004 13C-breath tests in hepatology (cytosolic liver function) Eur. Rev. Med. Pharmacol. Sci. 8 47-9
52. Pepys M B and Hirschfield G M 2003 C-reactive protein: a critical update J. Clin. Investig. 111 1805-12
53. Damas P et al 2006 Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779] Crit. Care 10 R52
54. Zechman J M, Aldinger S and Labows J N Jr 1986 Characterization of pathogenic bacteria by automated headspace concentration-gas chromatography J. Chromatogr. 377 49-57
55. Preti G, Thaler E, Hanson C W, Troy M, Eades J and Gelperin A 2009 Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 877 2011-8
56. Vincent J L et al 2009 International study of the prevalence and outcomes of infection in intensive care units JAMA: J. Am. Med. Assoc. 302 2323-9
57. Maddula S, Blank L M, Schmid A and Baumbach J I 2009 Detection of volatile metabolites of E. coli by multi capillary column coupled ion mobility spectrometry Anal. Bioanal. Chem. 394 791-800
58. Bunge M et al 2008 On-line monitoring of microbial volatile metabolites by proton transfer reaction-mass spectrometry Appl. Environ. Microbiol. 74 2179-86
59. Scotter J M, Allardyce R A, Langford V S, Hill A and Murdoch D R 2006 The rapid evaluation of bacterial growth in blood cultures by selected ion flow tube-mass spectrometry (SIFT-MS) and comparison with the BacT/ALERT automated blood culture system J. Microbiol. Methods 65 628-31
60. Allardyce R A, Langford V S, Hill A L and Murdoch D R 2006 Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS) J. Microbiol. Methods 65 361-5
61. Junger M et al 2012 Ion mobility spectrometry for microbial volatile organic compounds: a new identification tool for human pathogenic bacteria Appl. Microbiol. Biotechnol. 93 2603-14
62. Jones R N 2010 Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia Clin. Infect. Dis. 51 S81-7 (Suppl 1)
63. Jordan A, Hansel A, Holzinger R and Lindinger W 1995 Acetonitrile and benzene in the breath of smokers and non-smokers investigated by proton transfer reaction mass spectrometry (PTR-MS) Int. J. Mass Spectrom. Ion Process 148 L1-3
64. Kischkel S, Miekisch W, Fuchs P and Schubert J K 2012 Breath analysis during one-lung ventilation in cancer patients Eur. Respir. J. 40 706-13
65. Trefz P et al 2013 Continuous real time breath gas monitoring in the clinical environment by proton-transfer-reaction-time-of-flight-mass spectrometry Anal. Chem. 85 10321-9
66. Julak J, Stranska E, Rosova V, Geppert H, Spanel P and Smith D 2006 Bronchoalveolar lavage examined by solid phase microextraction, gas chromatography-mass spectrometry and selected ion flow tube mass spectrometry J. Microbiol. Methods 65 76-86
67. Lee H J, Meinardi S, Pahl M V, Vaziri N D and Blake D R 2012 Exposure to potentially toxic hydrocarbons and halocarbons released from the dialyzer and tubing set during hemodialysis Am. J. Kidney Dis. 60 609-16
68. Walker V and Mills G A 2001 Urine 4-heptanone: a beta-oxidation product of 2-ethylhexanoic acid from plasticisers Clin. Chim. Acta 306 51-61
69. Wahl H G, Hong Q, Hildenbrand S, Risler T, Luft D and Liebich H 2004 4-Heptanone is a metabolite of the plasticizer di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients Nephrol. Dial. Transplant. 19 2576-83
70. Bos L D et al 2013 A simple breath sampling method in intubated and mechanically ventilated critically ill patients Respir. Physiol. Neurobiol. 191 67-74
71. Risby T H and Sehnert S S 1999 Clinical application of breath biomarkers of oxidative stress status Free Radic. Biol. Med. 27 1182-92
72. O'Hara M and Mayhew C A 2009 A preliminary comparison of volatile organic compounds in the headspace of cultures of S. Aureus grown in nutrient, dextrose and brain heart bovine broths measured using a proton transfer reaction mass spectrometer J. Breath Res. 3 027001
73. Meersseman W et al 2009 Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study Intensive Care Med. 35 1526-31
74. Hamet M et al 2012 Candida spp. Airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia Intensive Care Med. 38 1272-9
75. Azoulay E et al 2006 Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia Chest 129 110-7
76. Harriott M M and Noverr M C 2009 Candida albicans and S. Aureus form polymicrobial biofilms: effects on antimicrobial resistance Antimicrob. Agents Chemother. 53 3914-22
77. McAlester G, O'Gara F and Morrissey J P 2008 Signal-mediated interactions between P. Aeruginosa and C. Albicans J. Med. Microbiol. 57 563-9 (Pt 5)
78. Carlson E C 1988 Synergism of Candida albicans and delta toxin producing S. Aureus on mouse mortality and morbidity: protection by indomethacin Zentralbl. Bakteriol. Mikrobiol. Hyg. A 269 377-86
79. Ricard J D and Roux D 2012 Candida colonization in ventilated ICU patients: no longer a bystander! Intensive Care Med. 38 1243-5
80. Delisle M S, Williamson D R, Perreault M M, Albert M, Jiang X and Heyland D K 2008 The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients J. Crit. Care 23 11-7
81. Perl T et al 2011 Detection of characteristic metabolites of Aspergillus fumigatus and Candida species using ion mobility spectrometry-metabolic profiling by volatile organic compounds Mycoses 54 e828-37